Calvin Sternick
Stock Analyst at JP Morgan
(2.07)
# 3,017
Out of 4,996 analysts
19
Total ratings
46.15%
Success rate
7.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Calvin Sternick
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
USPH U.S. Physical Therapy | Maintains: Overweight | $120 → $110 | $83.40 | +31.89% | 5 | Mar 19, 2025 | |
CNC Centene | Maintains: Neutral | $85 → $80 | $34.86 | +129.49% | 4 | Jul 10, 2024 | |
PACS PACS Group | Initiates: Overweight | $27 | $13.98 | +93.13% | 1 | May 6, 2024 | |
UHS Universal Health Services | Maintains: Neutral | $144 → $182 | $200.85 | -9.39% | 3 | Mar 13, 2024 | |
THC Tenet Healthcare | Maintains: Overweight | $91 → $81 | $202.00 | -59.90% | 2 | Nov 17, 2023 | |
MOH Molina Healthcare | Maintains: Overweight | $367 → $392 | $191.98 | +104.19% | 4 | Nov 17, 2023 |
U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120 → $110
Current: $83.40
Upside: +31.89%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85 → $80
Current: $34.86
Upside: +129.49%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $13.98
Upside: +93.13%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144 → $182
Current: $200.85
Upside: -9.39%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91 → $81
Current: $202.00
Upside: -59.90%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367 → $392
Current: $191.98
Upside: +104.19%